Welcome to LookChem.com Sign In|Join Free
  • or
D-erythro-Pentonicacid,3-C-carboxy-5-[[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]amino]-2,4,5-trideoxy-5-oxo-4-[(1E)-9-oxo-1-hexadecen-1-yl]- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

147023-34-5

Post Buying Request

147023-34-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

147023-34-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 147023-34-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,7,0,2 and 3 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 147023-34:
(8*1)+(7*4)+(6*7)+(5*0)+(4*2)+(3*3)+(2*3)+(1*4)=105
105 % 10 = 5
So 147023-34-5 is a valid CAS Registry Number.

147023-34-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name (-)-viridiofungin A

1.2 Other means of identification

Product number -
Other names (S)-2-{(E)-(S)-1-[(S)-1-Carboxy-2-(4-hydroxy-phenyl)-ethylcarbamoyl]-10-oxo-heptadec-2-enyl}-2-hydroxy-succinic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:147023-34-5 SDS

147023-34-5Downstream Products

147023-34-5Relevant academic research and scientific papers

Total synthesis of viridiofungins A and B

Atkin, Liselle,Rizzacasa, Mark A.,Robertson, Angus,White, Jonathan M.

, p. 3557 - 3560 (2021)

The total synthesis of viridiofungins A (1) and B (2) via β-lactone 3 in 13 steps is reported. Key steps included an HF-mediated rearrangement of cyclobutene diester 9 to form a bicyclic lactone 6, an olefin cross metathesis between disubstituted alkene 3 and alkene 4 in which isomerization was suppressed, and a novel β-lactone ring opening to form the amide. Deprotection then gave either viridiofungin A (1) or B (2) in high yield.

A stereoselective synthesis of (-)-viridiofungin A utilizing a TiCl 4-promoted asymmetric multicomponent reaction

Ghosh, Arun K.,Kass, Jorden

, p. 510 - 512 (2012/03/26)

A stereoselective synthesis of (-)-viridiofungin A is described. The convergent synthesis utilized a unique highly diastereoselective multicomponent reaction between optically active phenyldihydrofuran and an α-ketoester to provide two chiral centers incl

REMEDY FOR VIRAL DISEASE

-

Page/Page column 27-28, (2010/02/14)

The object of the present invention is to provide a pharmaceutical composition for preventing or treating viral infectious diseases. The compounds of the present invention have extremely potent anti-HCV activity and HCV growth inhibitory effects, and sinc

Total synthesis of viridiofungin A

Morokuma, Kenji,Takahashi, Keisuke,Ishihara, Jun,Hatakeyama, Susumi

, p. 2265 - 2267 (2007/10/03)

Viridiofungin A, a member of amino alkyl citrate antibiotics from Trichoderma viride, was enantioselectively synthesized in naturally occurring form for the first time, employing regio- and stereoselective opening of the chiral glycidate with vinylmagnesi

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 147023-34-5